Hepatic Artery Embolization in 120 Patients with Unresectable Hepatoma

Overview

Journal Radiology

Specialty Radiology

Date 1983 Aug 1

PMID 6306721

Citations 265

Authors

R Yamada

M Sato

M Kawabata

H Nakatsuka

K Nakamura

S Takashima

Affiliations

Soon will be listed here.

Abstract

Transcatheter hepatic artery embolization was performed in 120 patients with unresectable hepatoma. The cumulative one-year survival rate was 44%. In most cases follow-up angiography revealed the selective disappearance of tumor vessels, and computed tomography demonstrated a marked decrease in tumor density without any changes in the surrounding liver parenchyma. Histologic examination in 14 cases confirmed these findings.

Citing Articles

Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?.

Abdelhamed W, Shousha H, El-Kassas M Liver Res. 2025; 8(3):141-151.

PMID: 39957750 PMC: 11771265. DOI: 10.1016/j.livres.2024.09.002.

Advancements in hydrogel-based embolic agents: Categorized by therapeutic mechanisms.

Zhang S, Lv R, Zhang Z, Wang Z, Jin Z Cancer Med. 2024; 13(20):e70183.

PMID: 39440706 PMC: 11497111. DOI: 10.1002/cam4.70183.

The combination of transarterial chemoembolization and microwave ablation is superior to microwave ablation alone for liver metastases from colorectal cancer.

Vogl T, Stefan H, Gruber-Rouh T, Trojan J, Bechstein W, Bielfeldt J J Cancer Res Clin Oncol. 2024; 150(10):440.

PMID: 39354218 PMC: 11445293. DOI: 10.1007/s00432-024-05951-8.

Efficacy and features of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: a narrative review.

Ishikawa T Transl Gastroenterol Hepatol. 2024; 9:48.

PMID: 39091662 PMC: 11292099. DOI: 10.21037/tgh-23-117.

The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes.

Cespiati A, Smith D, Lombardi R, Fracanzani A Cancers (Basel). 2024; 16(13).

PMID: 39001378 PMC: 11240545. DOI: 10.3390/cancers16132315.